Concentration-dependent effects on cell-free α-synuclein assembly
Biochemical assay · 100 μM recombinant α-synuclein in 100 mM Tris, pH 7.4 [2]
After six days, lower tested mannitol concentrations reduced fibrillation, whereas 0.9 M did not. Soluble oligomers responded differently: low concentrations did not prevent their formation, and 0.225 M increased oligomerization. Thus reduced fibril signal does not establish elimination of all aggregates.
| Endpoint | Reported result | Reference |
|---|---|---|
| Fibril formation relative to α-synuclein alone | reported result Reduced at 0.225 and 0.45 M (p < 0.005); no significant inhibition at 0.9 M | [2] |
| Soluble tetramers and higher oligomers | reported result 0.9 M decreased these species; 0.225 and 0.45 M did not prevent higher oligomers; 0.225 M increased oligomerization | [2] |
Literature-Reported Treatment Conditions
- Treatment concentration
- 0.225, 0.45 and 0.9 M representative comparisons
- Exposure duration
- 6 days at 37 °C
- Method
- Incubation with agitation; α-synuclein alone comparator
- Vehicle
- 100 mM Tris, pH 7.4
- Reported limits
- Mannitol supplier, lot, stereochemical assay and replicate count/error-bar definition for Fig 1 are not specified in the inspected assay description/caption.
Methods and source locations
Compound reported in the paper: Mannitol; Compound label in the paper: Reported as mannitol
Results apply to the reported mannitol preparation and experimental model.
Experimental Procedures: ThT Fluorescence Assay, TEM, Determination of Soluble Oligomer Formation; Results Figs 1–2 and captions
Fibril formation relative to α-synuclein alone: ThT fluorescence, with mannitol fluorescence subtracted; endpoint samples examined by TEM — Fig 1A–E and caption; Results: fibrillation and TEM
Soluble tetramers and higher oligomers: Western blot of soluble fractions; qualitative comparison — Fig 2 and caption; Results: Mannitol Inhibits α-syn Oligomer Formation